Dose Conversion: 5 mg Ritalin to Focalin
5 mg of immediate-release methylphenidate (Ritalin) converts to 2.5 mg of dexmethylphenidate (Focalin).
Conversion Ratio
The conversion is straightforward: dexmethylphenidate is dosed at half (1/2) the total daily dose of racemic methylphenidate 1, 2. This 2:1 ratio is consistently recommended across clinical practice guidelines and FDA labeling.
Pharmacologic Basis
Dexmethylphenidate is the isolated d-threo-enantiomer of racemic methylphenidate, which is the pharmacologically active isomer responsible for therapeutic effects 3, 4, 5. Since racemic methylphenidate (Ritalin) contains 50% of the active d-isomer and 50% of the less active l-isomer, extracting only the active d-isomer allows for equivalent efficacy at half the dose 6.
Clinical Application
Starting dose equivalents from guidelines 1:
- Methylphenidate (MPH): 5 mg
- Dexmethylphenidate (DEX): 2.5 mg
Titration increments maintain the same 2:1 ratio:
- MPH increases by 5-10 mg per dose
- DEX increases by 2.5-5 mg per dose
Important Caveats
Early exposure differences exist despite dose equivalence. Research demonstrates that while total drug exposure (AUC) is bioequivalent between 0.3 mg/kg racemic methylphenidate and 0.15 mg/kg dexmethylphenidate, the partial AUC during the first 3 hours (pAUC₀₋₃ₕ) shows significantly less early d-methylphenidate exposure after racemic methylphenidate compared to pure dexmethylphenidate 7. Specifically, the 1-hour d-methylphenidate concentration after racemic methylphenidate was only 56% of that after the pure d-isomer 7.
This means: While 5 mg Ritalin and 2.5 mg Focalin provide equivalent total daily exposure, Focalin delivers faster onset and higher early peak concentrations. This may translate to more rapid symptom control but potentially increased early side effects (appetite suppression, insomnia) 6.
Practical Dosing Guidance
When converting from immediate-release Ritalin to immediate-release Focalin:
- Direct conversion: Use exactly half the methylphenidate dose
- Timing: Both are typically dosed twice daily (morning and noon) due to short duration of action 1
- Monitoring: Watch for enhanced early effects (both therapeutic and adverse) with Focalin due to higher early d-methylphenidate exposure 7
For extended-release formulations, the same 2:1 conversion ratio applies 2, 4.